Bionovis
Bionovis is a pioneer in the production and commercialization of biological and biosimilar medicines. Our mission is to build a healthier Brazil and world through scientific innovation and highly complex medicines. We focus on research, development, manufacturing, and marketing of biopharmaceuticals, aiming to expand access to treatments and improve patient health. With over a decade of experience, strategic partnerships, and a commitment to quality and ethics, Bionovis strives to be a leading biopharmaceutical company in Latin America and globally.
Industries
Nr. of Employees
medium (51-250)
Bionovis
Rua Dr. José Gustavo da Costa, 100 - Valinhos, SP, Brazil
Products
Pegfilgrastim (pegfilgrastim therapeutic)
A biologic indicated to stimulate production of white blood cells to reduce infection risk in patients undergoing certain treatments such as chemotherapy.
Adalimumab (anti-TNF monoclonal antibody)
Monoclonal antibody indicated for various autoimmune conditions including rheumatoid arthritis, Crohn's disease and psoriasis.
Interferon beta-1a (immunomodulator)
Immunomodulatory therapy indicated for treatment of multiple sclerosis to reduce relapse rate and disease progression.
Etanercept (TNF inhibitor)
Biologic indicated for autoimmune diseases such as rheumatoid arthritis and psoriasis.
Golimumab (anti-TNF monoclonal antibody)
Monoclonal antibody indicated for treatment of rheumatoid arthritis and related autoimmune conditions.
Infliximab (anti-TNF monoclonal antibody)
Monoclonal antibody for treatment of autoimmune diseases including Crohn's disease and ulcerative colitis.
Pegfilgrastim (pegfilgrastim therapeutic)
A biologic indicated to stimulate production of white blood cells to reduce infection risk in patients undergoing certain treatments such as chemotherapy.
Adalimumab (anti-TNF monoclonal antibody)
Monoclonal antibody indicated for various autoimmune conditions including rheumatoid arthritis, Crohn's disease and psoriasis.
Interferon beta-1a (immunomodulator)
Immunomodulatory therapy indicated for treatment of multiple sclerosis to reduce relapse rate and disease progression.
Etanercept (TNF inhibitor)
Biologic indicated for autoimmune diseases such as rheumatoid arthritis and psoriasis.
Golimumab (anti-TNF monoclonal antibody)
Monoclonal antibody indicated for treatment of rheumatoid arthritis and related autoimmune conditions.
Infliximab (anti-TNF monoclonal antibody)
Monoclonal antibody for treatment of autoimmune diseases including Crohn's disease and ulcerative colitis.
Services
On-site industrial manufacturing of clinical and commercial batches for complex biological medicines, including process transfer and production at an industrial GMP-capable facility.
Services to receive and implement partner production technologies and licensing arrangements to enable local manufacture and commercialization of biologics.
Pilot plant operations for early-stage process development and test-batch production using bioreactors up to 200 L to support optimization and scale-up activities.
On-site analytical laboratory testing to verify product quality attributes and support regulatory-grade product release and stability programs.
Project-based support for non-clinical in vitro and in vivo studies integrated with upstream/downstream development to produce data for regulatory submissions.
On-site industrial manufacturing of clinical and commercial batches for complex biological medicines, including process transfer and production at an industrial GMP-capable facility.
Services to receive and implement partner production technologies and licensing arrangements to enable local manufacture and commercialization of biologics.
Pilot plant operations for early-stage process development and test-batch production using bioreactors up to 200 L to support optimization and scale-up activities.
On-site analytical laboratory testing to verify product quality attributes and support regulatory-grade product release and stability programs.
Project-based support for non-clinical in vitro and in vivo studies integrated with upstream/downstream development to produce data for regulatory submissions.
Expertise Areas
- Biopharmaceutical manufacturing
- Biosimilar development
- Cell line development and cell banking
- Upstream and downstream process development
Key Technologies
- Mammalian cell culture
- Single-use bioreactors
- Fed-batch bioreactor processes
- Continuous perfusion bioreactor processes
News & Updates
Impact on Lives
Bionovis has impacted over 1 million lives through its medicines.
Sales Milestone
Sold more than 16 million medicines across Brazil.
Scientific Advances
Exploring scientific progress in biopharmaceuticals.
Partnerships
Building collaborations with global leaders in pharma and public labs.
Company Overview
Bionovis's mission and focus on innovation in biopharmaceuticals.
Technological Leadership
Advances in biotechnology and manufacturing capabilities.
Impact on Lives
Bionovis has impacted over 1 million lives through its medicines.
Sales Milestone
Sold more than 16 million medicines across Brazil.
Scientific Advances
Exploring scientific progress in biopharmaceuticals.
Partnerships
Building collaborations with global leaders in pharma and public labs.
Company Overview
Bionovis's mission and focus on innovation in biopharmaceuticals.
Technological Leadership
Advances in biotechnology and manufacturing capabilities.